Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
+0.18%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$325B
AUM Growth
+$325B
Cap. Flow
-$12.6B
Cap. Flow %
-3.89%
Top 10 Hldgs %
22.35%
Holding
3,384
New
87
Increased
887
Reduced
2,270
Closed
46

Sector Composition

1 Technology 25.57%
2 Financials 13.1%
3 Healthcare 12.32%
4 Consumer Discretionary 12.3%
5 Communication Services 9.85%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NL icon
3251
NL Industries
NL
$320M
$214K ﹤0.01% 34,748 -1,155 -3% -$7.11K
RPID icon
3252
Rapid Micro Biosystems
RPID
$107M
$200K ﹤0.01% +10,806 New +$200K
MIRM icon
3253
Mirum Pharmaceuticals
MIRM
$3.71B
$199K ﹤0.01% 11,020
CYT
3254
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$193K ﹤0.01% +10,992 New +$193K
ABOS icon
3255
Acumen Pharmaceuticals
ABOS
$82.4M
$192K ﹤0.01% +12,922 New +$192K
ALPN
3256
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$184K ﹤0.01% 18,446
YI
3257
111 Inc
YI
$55.7M
$183K ﹤0.01% 29,713 -64,564 -68% -$398K
LEGH icon
3258
Legacy Housing
LEGH
$667M
$182K ﹤0.01% 10,412 -15,690 -60% -$274K
DTP
3259
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
0
EPIX icon
3260
ESSA Pharma
EPIX
$11.4M
$181K ﹤0.01% +22,642 New +$181K
ATER icon
3261
Aterian
ATER
$9.65M
$177K ﹤0.01% 15,982 -41,394 -72% -$458K
SRGA
3262
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$177K ﹤0.01% 162,222
FNCH
3263
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$176K ﹤0.01% 12,002
OMIC
3264
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$169K ﹤0.01% +15,128 New +$169K
ASPU
3265
DELISTED
ASPEN GROUP, INC.
ASPU
$164K ﹤0.01% 29,461
SPRB
3266
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$164K ﹤0.01% 23,018 -6,598 -22% -$47K
SGTX
3267
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$163K ﹤0.01% 26,747 +2,384 +10% +$14.5K
CMLS
3268
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$158K ﹤0.01% 12,904
VERO icon
3269
Venus Concept
VERO
$4.11M
$157K ﹤0.01% 62,738
LSEA
3270
DELISTED
Landsea Homes
LSEA
$153K ﹤0.01% 17,838 +4,154 +30% +$35.6K
MBII
3271
DELISTED
Marrone Bio Innovations, Inc.
MBII
$151K ﹤0.01% 172,042 -49,541 -22% -$43.5K
TERN icon
3272
Terns Pharmaceuticals
TERN
$609M
$150K ﹤0.01% 14,237
XPOF icon
3273
Xponential Fitness
XPOF
$295M
$145K ﹤0.01% +11,400 New +$145K
GHG
3274
GreenTree Hospitality
GHG
$213M
$140K ﹤0.01% +17,128 New +$140K
LNSR icon
3275
LENSAR
LNSR
$147M
$137K ﹤0.01% 17,865